— · biotech · life sciences · single-cell analysis
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Undisclosed round · Apr 2026 · $27M
ARCH Venture Partners lead, M Ventures, +ND Capital, Illumina Ventures, Longwall Venture Partners, OMX Ventures
Reported by Ventureburn
Missing a round, or an investor who was in one? Tell us.